
|Articles|August 1, 2003
Supplements and Featured Publications
- Examining the Dyslipidemia Constellation
- Volume 9
- Issue 1 Dyslipid
IVUS is redefining atherosclerotic disease
Author(s)Steven E. Nissen, MD
Advertisement
Articles in this issue
over 22 years ago
NCEP ATP III guidelines incorporate global risk assessmentover 22 years ago
Case reports illustrate consequences of ATP III in practiceover 22 years ago
Inflammatory markers are useful risk assessment toolsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
RSV Vaccination Effective in Older Adults, but Protection Declines Over Time
2
Discontinuing GLP-1s Before or Early in Pregnancy Tied to Weight Gain, Pregnancy Complications
3
Older Adults Drive Hospitalizations, Costs in the US 2024-2025 Influenza Season
4
Tapinarof Shows Strong Efficacy, Sleep Benefits in Pediatric AD Across Comorbidities: Druhan Howell, MD
5















































